yahoo_financeOriginal article
BioVie reports positive Phase 2 results for Parkinson's candidate bezisterim
Phase 2positivebezisterimPositive
AI Analysis
Summary
BioVie reported positive Phase 2 results for its Parkinson's disease candidate bezisterim. The positive data represents progress in the clinical development of the therapeutic candidate.
Clinical Trial Data
Phase
2
Primary Endpoint
Met
Importance:7/10
Sentiment:
0.75
Phase 2Parkinson's diseaseclinical trialpositive data
Related Companies
Read the original article
Published by yahoo_finance on August 6, 2026 1:03 PM